spacer
spacer

PDBsum entry 3eot

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system PDB id
3eot

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
212 a.a. *
214 a.a. *
Waters ×204
* Residue conservation analysis
PDB id:
3eot
Name: Immune system
Title: Crystal structure of lac031, an engineered anti-vla1 fab
Structure: Fab fragment, heavy chain. Chain: h. Engineered: yes. Mutation: yes. Fab fragment, light chain. Chain: l. Engineered: yes
Source: Mus musculus. Mouse. Organism_taxid: 10090. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
Resolution:
1.90Å     R-factor:   0.234     R-free:   0.270
Authors: P.A.Boriack-Sjodin,L.A.Clark
Key ref: L.A.Clark et al. (2009). An antibody loop replacement design feasibility study and a loop-swapped dimer structure. Protein Eng Des Sel, 22, 93. PubMed id: 19074157
Date:
29-Sep-08     Release date:   20-Jan-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
No UniProt id for this chain
Struc: 212 a.a.
Protein chain
No UniProt id for this chain
Struc: 214 a.a.
Key:    Secondary structure  CATH domain

 

 
Protein Eng Des Sel 22:93 (2009)
PubMed id: 19074157  
 
 
An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
L.A.Clark, P.A.Boriack-Sjodin, E.Day, J.Eldredge, C.Fitch, M.Jarpe, S.Miller, Y.Li, K.Simon, H.W.van Vlijmen.
 
  ABSTRACT  
 
A design approach was taken to investigate the feasibility of replacing single complementarity determining region (CDR) antibody loops. This approach may complement simpler mutation-based strategies for rational antibody design by expanding conformation space. Enormous crystal structure diversity is available, making CDR loops logical targets for structure-based design. A detailed analysis for the L1 loop shows that each loop length takes a distinct conformation, thereby allowing control on a length scale beyond that accessible to simple mutations. The L1 loop in the anti-VLA1 antibody was replaced with the L2 loop residues longer in an attempt to add an additional hydrogen bond and fill space on the antibody-antigen interface. The designs expressed well, but failed to improve affinity. In an effort to learn more, one design was crystallized and data were collected at 1.9 A resolution. The designed L1 loop takes the qualitatively desired conformation; confirming that loop replacement by design is feasible. The crystal structure also shows that the outermost loop (residues Leu51-Ser68) is domain swapped with another monomer. Tryptophan fluorescence measurements were used to monitor unfolding as a function of temperature and indicate that the loop involved in domain swapping does not unfold below 60 degrees C. The domain-swapping is not directly responsible for the affinity loss, but is likely a side-effect of the structural instability which may contribute to affinity loss. A second round of design was successful in eliminating the dimerization through mutation of a residue (Leu51Ser) at the joint of the domain-swapped loop.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20847101 R.J.Pantazes, and C.D.Maranas (2010).
OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.
  Protein Eng Des Sel, 23, 849-858.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer